Anti-oxidative and TNF-α suppressive activities of puerarin derivative (4AC) in RAW264.7 cells and collagen-induced arthritic rats

European Journal of Pharmacology

Volumn 666, Issue 1-3, 2011, Pages 242-250

  Xiao, Cheng ^a   Li, Jian ^b,c   Dong, Xinxin ^c   He, Xiaojuan ^c   Niu, Xuyan ^c   Liu, Cha ^d   Zhong, Guoyue ^e   Bauer, Rudolf ^f   Yang, Dajian ^d,e   Lu, Aiping ^c  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

^e CHONGQING ACADEMY OF CHINESE MATERIA MEDICA   (China)

^f UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anti oxidative; Collagen induced arthritis; RAW264.7; Tetraacetyl puerarin; TNF

Indexed keywords

2',3'',4'',6'' TETRAACETYL PUERARIN; ANTIOXIDANT; COLLAGEN TYPE 2; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; PUERARIN; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MACROPHAGE; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARTHRITIS; CATTLE; CELL LINE; CELL SURVIVAL; COLLAGEN TYPE II; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; ISOFLAVONES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NF-KAPPA B; PHOSPHORYLATION; PHYSICOCHEMICAL PROCESSES; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960016920     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.05.061     Document Type: Article

References (38)

1. K. Ayhan, N. Mustafa, A. Nurettin, and H. Cengiz Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis Cell Biochem. Funct. 22 2004 53 57
2. L. Bebrevska, K. Foubert, N. Hermans, S. Chatterjee, E. Van Marck, G. De Meyer, A. Vlietinck, L. Pieters, and S. Apers In vivo antioxidative activity of a quantified puerarin lobata root extract J. Ethnopharmacol. 127 2010 112 117
3. W. Cao, C. Bao, E. Padalko, and C.J. Lowenstein Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling J. Exp. Med. 205 2008 1491 1503 (Pubitemid 351831502)
4. C.C. Chen, P.C. Tsai, B.L. Wei, and W.F. Chiou 8-Prenylkaempferol suppresses inducible nitric oxide synthase expression through interfering with JNK-mediated AP-1 pathway in murine macrophages Eur. J. Pharmacol. 590 2008 430 436
5. Y.W. Cheng, C.Y. Chang, K.L. Lin, C.M. Hu, C.H. Lin, and J.J. Kang Shikonin derivatives inhibited LPS-induced iNOS in RAW 264.7 cells via downregulation of MAPK/NF-kB signaling J. Ethnopharmacol. 120 2008 264 271
6. Y.G. Cho, M.L. Cho, S.Y. Min, and H.Y. Kim Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis Autoimmun. Rev. 7 2007 65 70
7. M.J. Chung, N.J. Sung, C.S. Park, D.K. Kweon, A. Mantovani, T.W. Moon, S.J. Lee, and K.H. Park Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57BL/6J mice Eur. J. Phamacol. 578 2008 159 170 (Pubitemid 350309595)
8. M. De Bandt, M. Grossin, F. Driss, J. Pincemail, C. Babin-Chevaye, and C. Pasquier Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis Arthritis Rheum. 46 2002 522 532 (Pubitemid 34136591)
9. M. Feldmann, F.M. Brennan, and R.N. Maini Role of cytokines in rheumatoid arthritis Aunu. Rev. Innunol. 14 1996 397 440 (Pubitemid 26130190)
10. D.E. Furst Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis Clin. Exp. Rheumatol. 28 2010 S5 S12
11. M.B. Goldring The role of the chondrocyte in osteoarthritis Arthritis Rheum. 43 2000 1916
12. D. Guo, D. Yang, and S. Chen Pharmacokinetic investigation of puerarin and derivatives in rats Journal of Shanxi College of Traditional Chinese Medicine. 31 2008 52 55 (in Chinese)
13. D. Guo, S. Chen, and D. Yang Pharmacokinetic investigation of suspension and nanoparticles of puerarin derivative 4AC in Beagle dogs Li Shi Zhen Medicine and Materia Medica research. 20 2009 197 198 (in Chinese)
14. Y.H. He, J. Zhou, Y.S. Wang, C. Xiao, Y. Tong, J.C. Tang, A.S. Chan, and A.P. Lu Anti-inflammatory and anti-oxidative effects of cherries on Treund's adjuvant-induced arthritis in rats Scand. J. Rheumatol. 35 2006 356 358 (Pubitemid 44601068)
15. M. Hegen, J.C. Keith Jr.; M. Collins, and C.L. Nickerson-Nutter Utility of animal models for identification of potential therapeutics for rheumatoid arthritis Ann. Rheum. Dis. 67 2008 1505 1515
16. C.A. Hitchon, and H.S. El-Gabalawy Oxidation in rheumatoid arthritis Arthritis Res. Ther. 6 2004 265 278 (Pubitemid 39490014)
17. W. Hu, Q. Zhang, X. Yang, Y. Wang, and L. Sun Puerarin inhibits adhesion molecule expression in TNF-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway Pharmacol. 85 2010 27 35
18. Y.P. Hwang, and H.G. Jeong Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI 3K/Akt and HO-1 Toxicol. Appl. Pharmacol. 233 2008 371 381
19. S. Jaswal, H.C. Mehta, A.K. Sood, and J. Kaur Antioxidant status in rheumatoid arthritis and role of antioxidant therapy Clin. Chim. Acta 338 2003 123 129 (Pubitemid 37456698)
20. A. Kamanli, M. Naziroǧlu, N. Aydilek, and C. Hacievliyagil Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis Cell Biochem. Funct. 22 2004 53 57 (Pubitemid 38113621)
21. F. Karatas, I. Ozates, H. Canatan, I. Halifeoglu, M. Karatepe, and R. Colakt Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis Indian J. Med. Res. 118 2003 178 181 (Pubitemid 38008133)
22. P. Larsson, S. Kleinau, R. Holmdahl, and L. Klareskog Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation Arthritis Rheum. 33 1990 693 701 (Pubitemid 20166571)
23. Q. Liu, Z. Lu, and L. Wang Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism J. Tongji Med. Univ. 20 2000 43 45 (in Chinese) (Pubitemid 33210417)
24. J. Nam, and P. Emery Aspects of TNF inhibitor therapy in rheumatoid arthritis Mod. Rheumatol. 20 2010 325 330
25. N. Parameswaran, and S. Patial Tumor necrosis factor-α signaling in macrophages Crit. Rev. Eukaryot. Gene Expr. 20 2010 87 103
26. A. Perdriger Infliximab in the treatment of rheumatoid arthritis Biologics. 3 2009 183 191
27. J.K. Prasain, K. Jones, Brissie, R. Moore, J.M. Wyss, and S. Barnes Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry J. Agric. Food Chem. 52 2004 3708 3712
28. J. Shivani, C.M. Harish, K.S. Arun, and K. Jasinder Antioxidant status in rheumatoid arthritis and role of antioxidant therapy Clinica Chimica Acta. 338 2003 123 129
29. S.E. Sweeney, and G.S. Firestein Rheumatoid arthritis: regulation of synovial inflammation Int. J. Biochem. Cell Biol. 36 2004 372 378 (Pubitemid 37542434)
30. T. Takeuchi, T. Nakanishi, Y. Tabushi, A. Hata, T. Shoda, T. Kotani, A. Shimizu, T. Takubo, S. Makino, and T. Hanafusa Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab) J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 855 2007 66 70 (Pubitemid 47077724)
31. Y. Tan, M. Liu, and B. Wu Puerarin for acute ischemic stroke Stroke 39 2008 2188
32. P.C. Taylor, and M. Feldmann Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis Nat. Rev. Rheumatol. 5 2009 578 582
33. P. Vasanthi, G. Nalini, and G. Rajasekhar Status of oxidative stress in rheumatoid arthritis Int. J. Rheum. Dis. 12 2009 29 33
34. F.L. Xiong, X.H. Sun, L. Gan, X.L. Yang, and H.B. Xu Puerarin protects rat pancreatic islets from damage by hydrogen peroxide Eur. J. Pharmacol. S29 2006 1 7
35. L.P. Yan, S.W. Chan, A.S.C. Chan, S.L. Chen, X.J. Ma, and H.X. Xu Puerarin decreased serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats Life Sci. 79 2006 324 330
36. O. Yesim, Y.A. Sevgi, S. Aylin, K. Erinc, S. Vesile, and S. Bolkan Oxidative status in rheumatoid arthritis Clin. Rheumatol. 26 2007 64 68
37. S.Y. Zhang, G. Chen, P.F. Wei, X.S. Huang, Y. Dai, Y.J. Shen, S.L. Chen, C.A. Sun-chi, and H.K. Xu The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction J. Asian Nat. Prod. Res. 10 2008 373 381
38. + cells in Peyer's patch of SD rats with collagen induced arthritis Int. Immunopharmacol. 6 2006 198 203 (Pubitemid 43052816)